Spots Global Cancer Trial Database for stomach cancer, adenocarcinoma
Every month we try and update this database with for stomach cancer, adenocarcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2) | NCT05620628 | Stomach Cancer,... | Durvalumab Savolitinib | 19 Years - | Samsung Medical Center | |
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT04384601 | Gastric Cancer Neoadjuvant Che... | Chemotherapy | 18 Years - 80 Years | Ruijin Hospital | |
Rucaparib Plus Ramucirumab With or Without Nivolumab in Advanced Gastric and Esophageal Adenocarcinoma | NCT03995017 | Esophagus Cance... Stomach Cancer,... | Rucaparib Ramucirumab Nivolumab | 18 Years - | University of Kansas Medical Center | |
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer | NCT04384601 | Gastric Cancer Neoadjuvant Che... | Chemotherapy | 18 Years - 80 Years | Ruijin Hospital |